Biostar Pharmaceuticals, Inc. Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31)
Biostar Pharmaceuticals, Inc. reported Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) of 124.95% for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsExpectedVolatilityRate · last filed 2017-11-20
- Biostar Pharmaceuticals, Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2017-03-31 was 124.95%, a 27.43% increase year-over-year.
- Biostar Pharmaceuticals, Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2016-03-31 was 98.05%, a 2.36% decline year-over-year.
- Biostar Pharmaceuticals, Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2015-03-31 was 100.42%.
- Biostar Pharmaceuticals, Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2016 was 124.95%.
| Period end | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-09-30 | 124.95% 10-Q · filed 2017-11-20 | |||
| 2017-06-30 | 124.95% 10-Q · filed 2017-11-15 | |||
| 2017-03-31 | 124.95% 10-Q · filed 2017-05-19 | |||
| 2016-12-31 | 124.95% 10-K · filed 2017-04-13 | |||
| 2016-09-30 | 149.91% 10-Q · filed 2016-11-21 | |||
| 2016-06-30 | 111.33% 10-Q · filed 2016-08-22 | |||
| 2016-03-31 | 98.05% 10-Q · filed 2016-05-23 | |||
| 2015-09-30 | 97.95% 10-Q · filed 2015-11-23 | |||
| 2015-06-30 | 99.01% 10-Q · filed 2015-08-19 | |||
| 2015-03-31 | 100.42% 10-Q · filed 2015-05-15 |